149 related articles for article (PubMed ID: 11703327)
1. Comparison of peripheral blood interphase cytogenetics with bone marrow karyotype analysis in myelofibrosis with myeloid metaplasia.
Tefferi A; Meyer RG; Wyatt WA; Dewald GW
Br J Haematol; 2001 Nov; 115(2):316-9. PubMed ID: 11703327
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of cytogenetics determined by fluorescent in situ hybridization in patients having myelofibrosis with myeloid metaplasia.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Gisslinger H; Zojer N; Ludwig H
Cancer; 2006 Dec; 107(12):2801-6. PubMed ID: 17103442
[TBL] [Abstract][Full Text] [Related]
3. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
4. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia.
Reeder TL; Bailey RJ; Dewald GW; Tefferi A
Blood; 2003 Mar; 101(5):1981-3. PubMed ID: 12406879
[TBL] [Abstract][Full Text] [Related]
5. Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia.
Andrieux J; Demory JL; Morel P; Plantier I; Dupriez B; Caulier MT; Bauters F; Laï JL
Cancer Genet Cytogenet; 2002 Aug; 137(1):68-71. PubMed ID: 12377417
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.
Mesa RA; Li CY; Schroeder G; Tefferi A
Blood; 2001 Jun; 97(11):3665-7. PubMed ID: 11369668
[TBL] [Abstract][Full Text] [Related]
7. Comparison of chromosomal rearrangements in bone marrow cells and blast transformed B-cells in relapse of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Andreieva SV; Korets KV; Ruzhinska OE; Skorokhod IM; Alkhimova OG
Exp Oncol; 2017 Jul; 39(2):141-144. PubMed ID: 29483496
[TBL] [Abstract][Full Text] [Related]
8. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
Tefferi A; Dingli D; Li CY; Dewald GW
Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
[TBL] [Abstract][Full Text] [Related]
9. [Study on the role of fluorescence in situ hybridization in cytogenetic evaluation of myelodysplastic syndrome].
Qu SQ; Xu ZF; Li CW; Liu XP; Qin TJ; Zhang Y; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):839-42. PubMed ID: 23384907
[TBL] [Abstract][Full Text] [Related]
10. Isochromosome 17q in a case of myelofibrosis with myeloid metaplasia terminating in blastic transformation.
Nakamura H; Sadamori N; Yamada Y; Yao E; Tagawa M; Nishino K; Sasagawa I; Kamihira S; Oyakawa Y; Tomonaga M
Cancer Genet Cytogenet; 1987 Feb; 24(2):221-4. PubMed ID: 3791175
[TBL] [Abstract][Full Text] [Related]
11. Study of cytogenetic abnormalities in G-CSF stimulated peripheral blood cells and non-stimulated bone marrow cells of patients with myelofibrosis.
Lozynskyy RY; Lozynska MR; Hontar YV; Huleyuk NL; Maslyak ZV; Novak VL
Exp Oncol; 2016 Mar; 38(1):40-4. PubMed ID: 27031718
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood cells in the study of chromosome aberrations of patients with chronic myeloid leukaemia or myelofibrosis.
Pakkala A; Ruutu T; Partanen S; Kovanen R; Borgström GH; Knuutila S
Acta Haematol; 1983; 70(4):264-8. PubMed ID: 6414213
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic studies in twelve patients with primary myelofibrosis and myeloid metaplasia.
Smadja N; Krulik M; de Gramont A; Sirinelli A; Brissaud P; Dray C; Audebert AA; Debray J
Cancer Genet Cytogenet; 1987 Jan; 24(1):151-8. PubMed ID: 3466667
[TBL] [Abstract][Full Text] [Related]
15. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
Cherry AM; Slovak ML; Campbell LJ; Chun K; Eclache V; Haase D; Haferlach C; Hildebrandt B; Iqbal AM; Jhanwar SC; Ohyashiki K; Sole F; Vandenberghe P; VanDyke DL; Zhang Y; Dewald GW
Leuk Res; 2012 Jul; 36(7):832-40. PubMed ID: 22537394
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia.
Tefferi A; Mesa RA; Schroeder G; Hanson CA; Li CY; Dewald GW
Br J Haematol; 2001 Jun; 113(3):763-71. PubMed ID: 11380468
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosis.
Solé F; de Pablos JM; Woessner S; Pérez MM; Jurado M; Espinet B; Grao P; Moratalla A; Esquivias J
Cancer Genet Cytogenet; 1997 Apr; 94(2):147-50. PubMed ID: 9109946
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
Braulke F; Schulz X; Germing U; Schuler E; Platzbecker U; Nolte F; Hofmann WK; Giagounidis A; Götze K; Lübbert M; Schlenk RF; Schanz J; Bacher U; Ganser A; Büsche G; Letsch A; Schafhausen P; Bug G; Brümmendorf TH; Haas R; Trümper L; Shirneshan K; Haase D
Ann Hematol; 2017 Jun; 96(6):887-894. PubMed ID: 28374162
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetics and molecular genetics in myelofibrosis with myeloid metaplasia and polycythemia vera].
Roche-Lestienne C; Andrieux J
Pathol Biol (Paris); 2007 Feb; 55(1):49-55. PubMed ID: 16901657
[TBL] [Abstract][Full Text] [Related]
20. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
